OasisLMS

This talk will review understanding female NLUTD using a neuroscience construct.  With this foundation, medical and surgical treatments for female NLUTD will be discussed.  The treatment goals underlies how we approach to treating NLUTD will be discussed.

At the end of this webinar, participants will:

• Understand how neuroanatomy and neurophysiology of female lower urinary tract (bladder/urethra/pelvic floor) regulate normal urinary storage and emptying functions.
• Be able to describe medical and surgical treatments for female patients with neurologic diseases (“female neurogenic lower urinary tract dysfunction” or F-NLUTD).

Toby C. Chai, MD, is the Richard K. Babayan Professor and Chair of the Department of Urology at Boston University Chobanian & Avedisian School of Medicine (BU-CASM). He is also Chief of Urology at Boston Medical Center and President of Boston University Medical Center Urologists, Inc.

Dr. Chai completed his M.D. degree at Indiana University School of Medicine, his urology residency at University of Michigan Medical Center, and a post-doctoral research fellowship at University of Virginia. Prior to joining BU-CASM, he held the John D. Young Professorship in Urology at the University of Maryland School of Medicine and was Vice Chair of Research in the Department of Urology at Yale University School of Medicine.

Dr. Chai has been Principal Investigator on NIH R01, P20 and U01 grants. He has published 180 original research papers, reviews, and medical texts. His peers have recognized him for significant contributions to the field with these awards: 1. The 2022 American Urological Association (AUA) Distinguished Service Award for exemplary contributions to the science of urology and advocacy for urological research; 2. The 2015 Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Distinguished Service Award and for his contributions to the field and exemplary service to the Society; 3. The 2013 AUA Victor A. Politano Award for outstanding work in treatment of urinary incontinence and innovations in bladder research; 4. The 2005 SUFU McGuire-Zimskind Award for a Society member within ten years of completing residency or fellowship who has made significant contributions to the field, primarily through basic and clinical research, and has shown great potential for continuing and progressive scholarship. The patient advocacy group National Association for Continence awarded Dr. Chai the 2022 Continence Champion Award (Rodney Appell Award) which is given to an outstanding healthcare professional who has excelled in research, clinical practice, and education for bladder and bowel health issue.

Dr. Chai has given back to the scientific and urologic community including service as member of editorial board of American Journal of Physiology – Renal Physiology, Associate Editor of Journal of Urology, and Co-Editor-in-Chief of Bladder.   He has served as a charter member of the FDA Bone, Reproductive, and Urologic Drugs (BRUDAC) Advisory Committee and numerous NIH grant review panels.  He currently serves as a Trustee of the American Board of Urology.

The American Urogynecologic Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Urogynecologic Society designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the American Urogynecologic Society (AUGS) requires that individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies. AUGS mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AUGS seeks to verify that all scientific research referred to, reported, or used in a CME activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AUGS is committed to providing learners with high-quality CME.

Faculty Disclosures

Toby Chai is an advisor for GSK.

All relevant financial conflicts have been mitigated.

Planner and Staff Disclosures

None of the other planners, reviewers, or AUGS staff have any relevant financial relationships to disclose.